Cart
sales@molnova.com
Inbakicept
CAS No. 2135939-52-3
Inbakicept( —— )
Catalog No. M36799 CAS No. 2135939-52-3
Inbakicept (ALT 803) is a fusion protein of the IL-15 receptor α-sushi binding domain IL-15RαSu and immunoglobulin G1 (human Fc fragment), which is an IL-15 superagonist protein complex.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 1477 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameInbakicept
-
NoteResearch use only, not for human use.
-
Brief DescriptionInbakicept (ALT 803) is a fusion protein of the IL-15 receptor α-sushi binding domain IL-15RαSu and immunoglobulin G1 (human Fc fragment), which is an IL-15 superagonist protein complex.
-
DescriptionInbakicept, also known as N-803 (Nogapendekin alfa inbakicept), contains the IL-15 cytokine antibody Nogapendekin alfa (HY-P99759). Inbakicept is a dimeric human IL-15 receptor alpha (IL-15 Ra) sushi domain/human IgG1 Fc fusion protein and is an IL-15 superagonist complex. Inbakicept amplifies anti-CD20 mAb-mediated NK cell responses and antibody-dependent cellular cytotoxicity (ADCC). Inbakicept also increases degranulation and IFNγ production in cells.
-
In VitroCell Cytotoxicity Assay Cell Line:Daudi, Raji, CD19+ FL cells Concentration:0.01 nM, 0.1 nM, and 1 nM Incubation Time:20 hours Result:Increased the human NK cell cytotoxicity on Daudi, Raji, CD19+ FL cells.
-
In VivoAnimal Model:SCID mice with Daudi models Dosage:0.02 mg/kg, 0.05 mg/kg, 0.1 mg/kg, and 0.2 mg/kg Administration:Intravenous injection; twice weekly, for 2 weeks Result:Enhanced rituximab-directed control of Raji lymphoma challenge.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2135939-52-3
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rosario M, et al. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. Clin Cancer Res. 2016 Feb 1;22(3):596-608. ?
molnova catalog
related products
-
Bredinin aglycone
Bredinin aglycone is a purine nucleotide analog. It can be used to examine the efficiency of catalysts for the preparation of purine nucleotide analogs.
-
Ginsenoside F4
Ginsenoside F4 has inhibitory effect on human lymphocytoma JK cell by inducing its apoptosis, the mechanism is related to the mitochondrial dysfunction and the increase of Bax expression and decrease of Bcl-2 expression.
-
Isophysalin A
Isophysalin A exhibits anti-inflammatory activitiy, it exhibits conjugating abilities with glutathione and also shows significant nitric oxide (NO) production inhibiting activities.
